New Neurology Therapies Added
We've expanded our neurology infusion offerings to include Leqembi, Kisunla, and additional MS treatments — coordinated directly with your neurologist.
Frontier Infusion Center has expanded its neurology infusion offerings, adding several new therapies to better serve patients living with neurological conditions across our service areas.
Newly administered therapies include treatments for Alzheimer's disease — such as Leqembi (lecanemab) and Kisunla (donanemab) — as well as additional infusion therapies for multiple sclerosis and other neurological conditions. Each treatment is coordinated directly with the patient's referring neurologist to ensure continuity of care.
Because these therapies often require careful monitoring and specific infusion protocols, our registered nurses are trained to administer them in a controlled, comfortable outpatient setting, with vitals monitored throughout every session.
Patients and referring physicians can contact our concierge team to confirm whether a specific therapy is available at their preferred location and to begin the referral and prior-authorization process.
Have questions about this update?
Our concierge team is happy to help.